ArticleNPJ systems biology and applications2026
Interpretable multitask model for clinical pathology image prediction and interpretation.
Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Deep learning (DL)-based pathological image modelling and analysis approaches offer transformative potential for early cancer diagnostics, yet limited sample sizes and a lack of interpretability often hinder efficient clinical translation. Here, we present the interpretable Multi-Task Digital Pathology Model (iMDPath), an end-to-end, highly explainable multi-task deep learning framework that simultaneously addresses these challenges by integrating data augmentation, diagnostic prediction, and visualization of pathological image features. The iMDPath comprises three modules: Augmentation (iMDPath-Aug), Prediction (iMDPath-Pred), and Visualization (iMDPath-Vis). iMDPath-Aug incorporates a vector-quantized variational autoencoder (VQ-VAE) for enhanced data augmentation, capturing essential pathological features from limited datasets. A Swin Transformer-Based (Swin-B) predictor in the iMDPath-Pred module leverages the augmented data to achieve better performance than patch-level and foundation-model-based encoders such as InceptionV3 and Phikon across six diverse cancer pathology datasets, including gastric, breast, lung, and colorectal cancer. Finally, iMDPath-Vis, a novel visualization module combining the full gradient (FullGrad) and occlusion sensitivity analysis, provides pathologists with actionable insights by highlighting the specific tissue regions driving model predictions. Overall, iMDPath not only surpasses existing methods in diagnostic accuracy, sensitivity, and generalization across these datasets, but also offers a transparent and interpretable AI solution for precision oncology, paving the way for more reliable and efficient clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.